 Robert Enzenauer
Concepts (542)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amblyopia | 7 | 2023 | 54 | 1.750 |
Why?
| | Ophthalmologic Surgical Procedures | 8 | 2019 | 82 | 1.510 |
Why?
| | Vision Screening | 4 | 2023 | 46 | 1.460 |
Why?
| | Retinopathy of Prematurity | 9 | 2021 | 156 | 1.400 |
Why?
| | Strabismus | 9 | 2017 | 61 | 1.220 |
Why?
| | Refractive Errors | 4 | 2023 | 33 | 1.190 |
Why?
| | Oculomotor Muscles | 11 | 2017 | 74 | 1.120 |
Why?
| | Cornea | 9 | 2021 | 150 | 1.110 |
Why?
| | Ophthalmology | 6 | 2021 | 104 | 0.840 |
Why?
| | Eye Injuries, Penetrating | 3 | 2013 | 20 | 0.780 |
Why?
| | Military Personnel | 8 | 2018 | 608 | 0.700 |
Why?
| | Military Medicine | 4 | 2016 | 129 | 0.700 |
Why?
| | Eye Injuries | 8 | 2016 | 53 | 0.690 |
Why?
| | Eye Foreign Bodies | 3 | 2014 | 26 | 0.670 |
Why?
| | Photography | 3 | 2010 | 108 | 0.650 |
Why?
| | Endophthalmitis | 5 | 2002 | 43 | 0.630 |
Why?
| | Chemical Warfare Agents | 6 | 2021 | 114 | 0.620 |
Why?
| | Patient Simulation | 1 | 2019 | 36 | 0.590 |
Why?
| | Exotropia | 4 | 2006 | 20 | 0.590 |
Why?
| | Lighting | 2 | 2016 | 29 | 0.580 |
Why?
| | Tensile Strength | 2 | 2017 | 96 | 0.570 |
Why?
| | Amnion | 1 | 2017 | 28 | 0.550 |
Why?
| | Equipment Design | 1 | 2019 | 518 | 0.530 |
Why?
| | Down Syndrome | 1 | 2023 | 483 | 0.520 |
Why?
| | Eye Infections, Bacterial | 3 | 2002 | 39 | 0.510 |
Why?
| | Teaching | 1 | 2019 | 233 | 0.500 |
Why?
| | Esotropia | 4 | 2006 | 25 | 0.490 |
Why?
| | Diagnostic Techniques, Ophthalmological | 3 | 2016 | 50 | 0.490 |
Why?
| | Color Vision | 1 | 2016 | 4 | 0.490 |
Why?
| | Color | 1 | 2016 | 78 | 0.480 |
Why?
| | Wound Healing | 3 | 2017 | 345 | 0.480 |
Why?
| | Neonatal Screening | 5 | 2021 | 167 | 0.450 |
Why?
| | Delivery of Health Care | 2 | 2013 | 963 | 0.430 |
Why?
| | Boxing | 5 | 1994 | 6 | 0.420 |
Why?
| | Ophthalmic Solutions | 5 | 2017 | 78 | 0.420 |
Why?
| | Tissue Adhesions | 2 | 2017 | 32 | 0.410 |
Why?
| | Humans | 117 | 2023 | 138972 | 0.400 |
Why?
| | Vitrectomy | 4 | 2007 | 77 | 0.390 |
Why?
| | Visual Acuity | 11 | 2013 | 428 | 0.390 |
Why?
| | Surgical Procedures, Operative | 1 | 2016 | 266 | 0.390 |
Why?
| | Retinoscopes | 1 | 2011 | 1 | 0.350 |
Why?
| | Rabbits | 8 | 2021 | 762 | 0.340 |
Why?
| | Insurance, Liability | 1 | 2010 | 5 | 0.340 |
Why?
| | Dacryocystitis | 1 | 2010 | 3 | 0.340 |
Why?
| | Mucocele | 1 | 2010 | 12 | 0.330 |
Why?
| | Nonprescription Drugs | 2 | 2003 | 64 | 0.330 |
Why?
| | Pupil Disorders | 1 | 2010 | 7 | 0.320 |
Why?
| | Mustard Gas | 3 | 2021 | 103 | 0.320 |
Why?
| | Infant, Newborn | 27 | 2021 | 6158 | 0.320 |
Why?
| | Corneal Injuries | 2 | 2021 | 46 | 0.320 |
Why?
| | Conjunctival Diseases | 2 | 2017 | 21 | 0.320 |
Why?
| | Reimbursement Mechanisms | 1 | 2010 | 83 | 0.310 |
Why?
| | Warfare | 3 | 2018 | 83 | 0.310 |
Why?
| | Sensitivity and Specificity | 6 | 2023 | 1939 | 0.300 |
Why?
| | Decompression, Surgical | 3 | 2019 | 113 | 0.290 |
Why?
| | Mechlorethamine | 3 | 2019 | 60 | 0.290 |
Why?
| | Surveys and Questionnaires | 8 | 2021 | 5884 | 0.290 |
Why?
| | Corneal Neovascularization | 3 | 2017 | 16 | 0.280 |
Why?
| | Developmental Disabilities | 1 | 2011 | 268 | 0.280 |
Why?
| | Vitreous Detachment | 1 | 2007 | 9 | 0.280 |
Why?
| | Optic Neuropathy, Ischemic | 1 | 2007 | 31 | 0.270 |
Why?
| | Optic Disk | 1 | 2007 | 52 | 0.260 |
Why?
| | Vitreous Body | 1 | 2007 | 121 | 0.260 |
Why?
| | Circumcision, Male | 5 | 1987 | 16 | 0.260 |
Why?
| | Arsenicals | 2 | 2017 | 30 | 0.260 |
Why?
| | Birth Weight | 5 | 2017 | 515 | 0.250 |
Why?
| | Weight Gain | 3 | 2016 | 538 | 0.250 |
Why?
| | Photorefractive Keratectomy | 1 | 2006 | 20 | 0.250 |
Why?
| | Horner Syndrome | 1 | 2006 | 6 | 0.240 |
Why?
| | Infant | 25 | 2017 | 9577 | 0.240 |
Why?
| | Orbit | 3 | 2013 | 71 | 0.240 |
Why?
| | Choristoma | 1 | 2006 | 20 | 0.240 |
Why?
| | Corneal Transplantation | 2 | 2005 | 13 | 0.240 |
Why?
| | Indans | 1 | 2005 | 12 | 0.240 |
Why?
| | Glaucoma, Angle-Closure | 1 | 2005 | 21 | 0.230 |
Why?
| | Nootropic Agents | 1 | 2005 | 29 | 0.230 |
Why?
| | Cataract Extraction | 3 | 2002 | 105 | 0.230 |
Why?
| | Neck | 1 | 2006 | 104 | 0.230 |
Why?
| | Hypergammaglobulinemia | 2 | 1999 | 9 | 0.230 |
Why?
| | Retinal Hemorrhage | 5 | 2013 | 22 | 0.230 |
Why?
| | Keratomileusis, Laser In Situ | 1 | 2005 | 20 | 0.230 |
Why?
| | Predictive Value of Tests | 3 | 2023 | 2030 | 0.220 |
Why?
| | Thymus Gland | 1 | 2006 | 314 | 0.220 |
Why?
| | Ocular Motility Disorders | 2 | 2003 | 32 | 0.220 |
Why?
| | Mathematical Computing | 1 | 2004 | 12 | 0.220 |
Why?
| | Vitamin A Deficiency | 1 | 2004 | 27 | 0.220 |
Why?
| | Multiple Sclerosis | 1 | 2010 | 460 | 0.210 |
Why?
| | Contact Lenses, Hydrophilic | 2 | 1997 | 7 | 0.210 |
Why?
| | Orbital Fractures | 1 | 2004 | 12 | 0.210 |
Why?
| | Vision, Ocular | 2 | 2016 | 44 | 0.210 |
Why?
| | Child | 17 | 2023 | 21936 | 0.210 |
Why?
| | Retinal Detachment | 2 | 2002 | 74 | 0.210 |
Why?
| | Piperidines | 1 | 2005 | 216 | 0.210 |
Why?
| | Corneal Diseases | 2 | 2015 | 44 | 0.200 |
Why?
| | Diplopia | 1 | 2003 | 26 | 0.200 |
Why?
| | Suture Techniques | 3 | 1999 | 121 | 0.190 |
Why?
| | Dry Eye Syndromes | 1 | 2003 | 54 | 0.190 |
Why?
| | Risk Factors | 9 | 2023 | 10385 | 0.190 |
Why?
| | Drug Costs | 1 | 2003 | 110 | 0.190 |
Why?
| | Eyelids | 3 | 2013 | 42 | 0.190 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3313 | 0.190 |
Why?
| | Intraocular Pressure | 6 | 2013 | 313 | 0.190 |
Why?
| | Astigmatism | 2 | 2011 | 17 | 0.190 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2003 | 239 | 0.190 |
Why?
| | Physical Examination | 1 | 2023 | 240 | 0.190 |
Why?
| | Granuloma, Foreign-Body | 1 | 2002 | 10 | 0.180 |
Why?
| | Male | 54 | 2020 | 68250 | 0.180 |
Why?
| | Blepharoptosis | 1 | 2002 | 12 | 0.180 |
Why?
| | Oculomotor Nerve Diseases | 1 | 2002 | 13 | 0.180 |
Why?
| | Sclerostomy | 1 | 2001 | 4 | 0.180 |
Why?
| | Abducens Nerve Diseases | 1 | 2002 | 12 | 0.180 |
Why?
| | Female | 47 | 2017 | 74016 | 0.180 |
Why?
| | Myopia | 2 | 2011 | 55 | 0.180 |
Why?
| | Epithelium, Corneal | 3 | 2017 | 43 | 0.180 |
Why?
| | Hospitalization | 3 | 2010 | 2228 | 0.180 |
Why?
| | Child, Preschool | 17 | 2020 | 11158 | 0.170 |
Why?
| | Echolalia | 1 | 2001 | 1 | 0.170 |
Why?
| | Vigabatrin | 1 | 2021 | 19 | 0.170 |
Why?
| | Aniridia | 1 | 2020 | 5 | 0.170 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2001 | 11 | 0.170 |
Why?
| | Tissue Donors | 2 | 2005 | 395 | 0.170 |
Why?
| | PAX6 Transcription Factor | 1 | 2020 | 21 | 0.170 |
Why?
| | Arthritis | 3 | 2017 | 101 | 0.170 |
Why?
| | Trabeculectomy | 1 | 2001 | 74 | 0.170 |
Why?
| | Immunoglobulin G | 2 | 1999 | 898 | 0.170 |
Why?
| | Codon, Nonsense | 1 | 2020 | 43 | 0.170 |
Why?
| | Infant, Low Birth Weight | 2 | 2017 | 142 | 0.170 |
Why?
| | Retinal Diseases | 5 | 1994 | 96 | 0.170 |
Why?
| | Eye Proteins | 1 | 2020 | 93 | 0.160 |
Why?
| | Cyclooxygenase 2 | 5 | 2021 | 176 | 0.160 |
Why?
| | Glaucoma, Open-Angle | 1 | 2001 | 105 | 0.160 |
Why?
| | Socioeconomic Factors | 3 | 2021 | 1312 | 0.160 |
Why?
| | Leadership | 1 | 2004 | 394 | 0.160 |
Why?
| | Drug Residues | 1 | 1999 | 5 | 0.160 |
Why?
| | Scleral Buckling | 1 | 1999 | 18 | 0.160 |
Why?
| | Sclera | 1 | 1999 | 37 | 0.160 |
Why?
| | Wilms Tumor | 1 | 2020 | 87 | 0.160 |
Why?
| | Prospective Studies | 7 | 2019 | 7661 | 0.160 |
Why?
| | Corneal Stroma | 2 | 2017 | 24 | 0.160 |
Why?
| | Organ Preservation Solutions | 1 | 1999 | 45 | 0.150 |
Why?
| | Disease Models, Animal | 3 | 2019 | 4316 | 0.150 |
Why?
| | Lacrimal Apparatus | 1 | 2019 | 9 | 0.150 |
Why?
| | Postoperative Complications | 3 | 2017 | 2716 | 0.150 |
Why?
| | Immunoglobulin lambda-Chains | 1 | 1999 | 9 | 0.150 |
Why?
| | Paraproteinemias | 1 | 1999 | 5 | 0.150 |
Why?
| | Functional Laterality | 2 | 2010 | 232 | 0.150 |
Why?
| | Retinal Vein Occlusion | 1 | 1999 | 13 | 0.150 |
Why?
| | Anticonvulsants | 1 | 2021 | 219 | 0.150 |
Why?
| | Organ Preservation | 1 | 1999 | 107 | 0.150 |
Why?
| | Face | 1 | 2020 | 173 | 0.150 |
Why?
| | Contrast Sensitivity | 1 | 2018 | 15 | 0.140 |
Why?
| | Pneumococcal Infections | 1 | 1999 | 110 | 0.140 |
Why?
| | Vision Tests | 1 | 2018 | 19 | 0.140 |
Why?
| | Staphylococcal Infections | 3 | 2011 | 387 | 0.140 |
Why?
| | Color Perception | 1 | 2018 | 26 | 0.140 |
Why?
| | United States | 13 | 2021 | 15074 | 0.140 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2021 | 133 | 0.140 |
Why?
| | Adolescent | 16 | 2016 | 21581 | 0.140 |
Why?
| | Naphazoline | 1 | 1997 | 1 | 0.140 |
Why?
| | Pheniramine | 1 | 1997 | 1 | 0.140 |
Why?
| | Retrobulbar Hemorrhage | 2 | 2009 | 4 | 0.140 |
Why?
| | Nasal Decongestants | 1 | 1997 | 8 | 0.140 |
Why?
| | Conjunctivitis, Allergic | 1 | 1997 | 5 | 0.140 |
Why?
| | Gestational Age | 6 | 2017 | 918 | 0.140 |
Why?
| | Histamine H1 Antagonists | 1 | 1997 | 28 | 0.140 |
Why?
| | Mydriasis | 1 | 1997 | 10 | 0.140 |
Why?
| | Athletic Injuries | 3 | 1989 | 515 | 0.140 |
Why?
| | Atropine | 1 | 2017 | 36 | 0.140 |
Why?
| | Nerve Agents | 1 | 2017 | 7 | 0.140 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 121 | 0.140 |
Why?
| | Conjunctiva | 1 | 2017 | 53 | 0.130 |
Why?
| | Farber Lipogranulomatosis | 1 | 2017 | 4 | 0.130 |
Why?
| | Meningitis | 3 | 1983 | 81 | 0.130 |
Why?
| | Antimetabolites | 1 | 1997 | 21 | 0.130 |
Why?
| | Synovitis | 1 | 2017 | 29 | 0.130 |
Why?
| | Adult | 21 | 2018 | 38393 | 0.130 |
Why?
| | Drug Therapy, Combination | 5 | 2012 | 1031 | 0.130 |
Why?
| | Quality Indicators, Health Care | 1 | 1999 | 308 | 0.130 |
Why?
| | Retrospective Studies | 15 | 2021 | 15901 | 0.130 |
Why?
| | Cicatrix | 1 | 1997 | 66 | 0.130 |
Why?
| | Orbital Neoplasms | 2 | 1993 | 26 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 563 | 0.120 |
Why?
| | Swine | 1 | 2019 | 800 | 0.120 |
Why?
| | False Positive Reactions | 2 | 2011 | 124 | 0.120 |
Why?
| | Kidney Neoplasms | 1 | 2020 | 395 | 0.120 |
Why?
| | Educational Measurement | 1 | 2019 | 300 | 0.120 |
Why?
| | Infant, Newborn, Diseases | 3 | 1982 | 115 | 0.120 |
Why?
| | Fluorouracil | 1 | 1997 | 204 | 0.120 |
Why?
| | Health Personnel | 2 | 2000 | 734 | 0.120 |
Why?
| | Antidotes | 1 | 2017 | 140 | 0.120 |
Why?
| | Uveitis | 1 | 2017 | 146 | 0.120 |
Why?
| | Treatment Outcome | 10 | 2011 | 10921 | 0.120 |
Why?
| | Afghanistan | 2 | 2007 | 79 | 0.120 |
Why?
| | Convergence, Ocular | 1 | 1995 | 6 | 0.120 |
Why?
| | Visual Fields | 3 | 2007 | 115 | 0.120 |
Why?
| | Household Products | 1 | 2015 | 6 | 0.120 |
Why?
| | Fibrosis | 1 | 2017 | 539 | 0.110 |
Why?
| | Eye Burns | 1 | 2015 | 14 | 0.110 |
Why?
| | Ethanol | 1 | 1999 | 615 | 0.110 |
Why?
| | Algorithms | 3 | 2017 | 1730 | 0.110 |
Why?
| | Public Health | 1 | 2000 | 582 | 0.110 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 325 | 0.110 |
Why?
| | Burns, Chemical | 1 | 2015 | 32 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 6 | 2010 | 3636 | 0.110 |
Why?
| | Animals | 9 | 2021 | 37243 | 0.110 |
Why?
| | Quality of Health Care | 1 | 1999 | 657 | 0.110 |
Why?
| | Interleukin-8 | 3 | 2021 | 271 | 0.110 |
Why?
| | Keratitis | 2 | 2017 | 18 | 0.110 |
Why?
| | Slit Lamp | 1 | 2014 | 2 | 0.110 |
Why?
| | Hyphema | 1 | 2013 | 5 | 0.110 |
Why?
| | Vascular Endothelial Growth Factor A | 4 | 2019 | 550 | 0.100 |
Why?
| | Keratotomy, Radial | 1 | 1993 | 10 | 0.100 |
Why?
| | Lymphangioma | 1 | 1993 | 9 | 0.100 |
Why?
| | Blindness | 2 | 2009 | 48 | 0.100 |
Why?
| | Health Care Surveys | 2 | 2010 | 567 | 0.100 |
Why?
| | Scleral Diseases | 1 | 1992 | 2 | 0.100 |
Why?
| | DNA Damage | 1 | 2016 | 422 | 0.100 |
Why?
| | Staphylococcus | 2 | 2011 | 75 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2002 | 1068 | 0.100 |
Why?
| | Abducens Nerve | 1 | 1992 | 3 | 0.100 |
Why?
| | Skull Neoplasms | 1 | 1992 | 21 | 0.100 |
Why?
| | Dura Mater | 1 | 1992 | 34 | 0.100 |
Why?
| | Eye Infections, Fungal | 1 | 1992 | 20 | 0.100 |
Why?
| | Anesthetics, Dissociative | 1 | 2012 | 34 | 0.100 |
Why?
| | Biomarkers | 2 | 2021 | 4095 | 0.100 |
Why?
| | Glucocorticoids | 4 | 2017 | 528 | 0.090 |
Why?
| | Opportunistic Infections | 1 | 1992 | 45 | 0.090 |
Why?
| | Hospitals, Military | 3 | 2007 | 28 | 0.090 |
Why?
| | Cranial Nerve Diseases | 1 | 1992 | 42 | 0.090 |
Why?
| | Doxycycline | 1 | 2012 | 61 | 0.090 |
Why?
| | Craniocerebral Trauma | 3 | 2013 | 170 | 0.090 |
Why?
| | Child Abuse | 3 | 2013 | 546 | 0.090 |
Why?
| | Paralysis | 1 | 1992 | 71 | 0.090 |
Why?
| | Follow-Up Studies | 8 | 2011 | 5152 | 0.090 |
Why?
| | Foreign Bodies | 1 | 2013 | 106 | 0.090 |
Why?
| | Double-Blind Method | 2 | 2011 | 1949 | 0.090 |
Why?
| | Ketamine | 1 | 2012 | 110 | 0.090 |
Why?
| | Cyclophosphamide | 2 | 2003 | 255 | 0.090 |
Why?
| | Vision, Binocular | 4 | 2005 | 41 | 0.090 |
Why?
| | Anisometropia | 1 | 2011 | 16 | 0.090 |
Why?
| | Hyperopia | 1 | 2011 | 17 | 0.090 |
Why?
| | Orbital Cellulitis | 1 | 2011 | 17 | 0.090 |
Why?
| | Middle Aged | 13 | 2016 | 33782 | 0.080 |
Why?
| | Silymarin | 1 | 2012 | 199 | 0.080 |
Why?
| | Gingivitis | 1 | 1990 | 12 | 0.080 |
Why?
| | Facial Pain | 1 | 1990 | 13 | 0.080 |
Why?
| | Aged | 13 | 2016 | 24172 | 0.080 |
Why?
| | Retina | 3 | 2021 | 304 | 0.080 |
Why?
| | Corneal Keratocytes | 2 | 2021 | 9 | 0.080 |
Why?
| | Malpractice | 1 | 2010 | 42 | 0.080 |
Why?
| | Fat Emulsions, Intravenous | 1 | 1990 | 29 | 0.080 |
Why?
| | Dexamethasone | 1 | 2012 | 375 | 0.080 |
Why?
| | Anti-Bacterial Agents | 4 | 2012 | 1811 | 0.080 |
Why?
| | Light | 1 | 2013 | 393 | 0.080 |
Why?
| | Immunoglobulin Light Chains | 1 | 1990 | 50 | 0.080 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2013 | 324 | 0.080 |
Why?
| | Fluorescein Angiography | 4 | 1999 | 167 | 0.080 |
Why?
| | Retinal Vessels | 1 | 1990 | 72 | 0.080 |
Why?
| | Drug Industry | 1 | 1990 | 109 | 0.080 |
Why?
| | Incidental Findings | 1 | 2010 | 79 | 0.080 |
Why?
| | Aerospace Medicine | 3 | 2014 | 32 | 0.080 |
Why?
| | Anti-Infective Agents | 2 | 2002 | 239 | 0.080 |
Why?
| | Nocardia Infections | 1 | 1989 | 10 | 0.070 |
Why?
| | Incidence | 4 | 2013 | 2830 | 0.070 |
Why?
| | Corneal Ulcer | 2 | 2004 | 21 | 0.070 |
Why?
| | Blood Vessels | 2 | 2021 | 180 | 0.070 |
Why?
| | Color Perception Tests | 1 | 2007 | 3 | 0.070 |
Why?
| | Enteral Nutrition | 1 | 1990 | 202 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 406 | 0.070 |
Why?
| | Autopsy | 1 | 2007 | 97 | 0.070 |
Why?
| | Urinary Tract Infections | 2 | 1987 | 193 | 0.070 |
Why?
| | Sudden Infant Death | 1 | 2007 | 28 | 0.070 |
Why?
| | Fundus Oculi | 6 | 1994 | 74 | 0.060 |
Why?
| | Immunosuppressive Agents | 2 | 2003 | 848 | 0.060 |
Why?
| | Eye Movements | 3 | 2005 | 82 | 0.060 |
Why?
| | Prevalence | 2 | 2013 | 2745 | 0.060 |
Why?
| | Accidents, Traffic | 2 | 2013 | 186 | 0.060 |
Why?
| | Shaken Baby Syndrome | 1 | 2006 | 5 | 0.060 |
Why?
| | Chromosome Inversion | 1 | 1986 | 18 | 0.060 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2006 | 8 | 0.060 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 1986 | 54 | 0.060 |
Why?
| | Nasolacrimal Duct | 1 | 2006 | 10 | 0.060 |
Why?
| | Videotape Recording | 1 | 1986 | 39 | 0.060 |
Why?
| | Infant, Very Low Birth Weight | 2 | 2017 | 70 | 0.060 |
Why?
| | Lasers, Excimer | 1 | 2006 | 29 | 0.060 |
Why?
| | Time Factors | 4 | 2017 | 6869 | 0.060 |
Why?
| | Refraction, Ocular | 1 | 2006 | 43 | 0.060 |
Why?
| | Optic Nerve Diseases | 1 | 2006 | 47 | 0.060 |
Why?
| | Parenteral Nutrition, Total | 1 | 1985 | 26 | 0.060 |
Why?
| | Tomography, Optical Coherence | 1 | 2007 | 234 | 0.060 |
Why?
| | Health Surveys | 2 | 2006 | 520 | 0.060 |
Why?
| | Skin Diseases, Infectious | 1 | 1985 | 14 | 0.060 |
Why?
| | Chromosome Aberrations | 1 | 1986 | 159 | 0.060 |
Why?
| | Diagnosis, Differential | 2 | 2006 | 1482 | 0.060 |
Why?
| | Cell Survival | 2 | 2021 | 1126 | 0.060 |
Why?
| | Colorado | 4 | 2017 | 4543 | 0.060 |
Why?
| | Quality Control | 1 | 2006 | 173 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 1992 | 882 | 0.060 |
Why?
| | Refractive Surgical Procedures | 1 | 2005 | 7 | 0.060 |
Why?
| | Smoking Prevention | 1 | 1986 | 183 | 0.060 |
Why?
| | Reoperation | 3 | 1999 | 579 | 0.060 |
Why?
| | Prostatic Neoplasms | 1 | 1992 | 1046 | 0.060 |
Why?
| | Pyoderma | 1 | 1984 | 3 | 0.060 |
Why?
| | Night Blindness | 1 | 2004 | 6 | 0.060 |
Why?
| | Myxoma | 1 | 1984 | 12 | 0.060 |
Why?
| | Ethics | 1 | 2004 | 10 | 0.060 |
Why?
| | Mitral Valve Stenosis | 1 | 1984 | 19 | 0.060 |
Why?
| | Xerophthalmia | 1 | 2004 | 7 | 0.060 |
Why?
| | Intellectual Disability | 1 | 1986 | 168 | 0.060 |
Why?
| | Organizational Objectives | 1 | 2004 | 66 | 0.050 |
Why?
| | Heart Neoplasms | 1 | 1984 | 56 | 0.050 |
Why?
| | Chloramphenicol | 1 | 1983 | 10 | 0.050 |
Why?
| | Theophylline | 1 | 1984 | 42 | 0.050 |
Why?
| | Ampicillin | 1 | 1983 | 14 | 0.050 |
Why?
| | Esophageal Diseases | 1 | 1984 | 28 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2006 | 364 | 0.050 |
Why?
| | Disability Evaluation | 1 | 2005 | 299 | 0.050 |
Why?
| | Tobacco Smoke Pollution | 1 | 1986 | 257 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 2 | 2012 | 475 | 0.050 |
Why?
| | Preservatives, Pharmaceutical | 1 | 2003 | 26 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2019 | 1730 | 0.050 |
Why?
| | Syndrome | 3 | 2020 | 377 | 0.050 |
Why?
| | Drug Packaging | 1 | 2003 | 43 | 0.050 |
Why?
| | Corneal Opacity | 2 | 2016 | 7 | 0.050 |
Why?
| | Pleura | 1 | 1983 | 24 | 0.050 |
Why?
| | Cholestasis | 1 | 1985 | 208 | 0.050 |
Why?
| | Intermittent Positive-Pressure Ventilation | 1 | 1983 | 12 | 0.050 |
Why?
| | Femoral Fractures | 2 | 1992 | 78 | 0.050 |
Why?
| | Cross Infection | 1 | 1985 | 249 | 0.050 |
Why?
| | Illinois | 2 | 2000 | 45 | 0.050 |
Why?
| | Counseling | 1 | 1986 | 392 | 0.050 |
Why?
| | Drug Combinations | 2 | 1997 | 346 | 0.050 |
Why?
| | Methylprednisolone | 1 | 2003 | 63 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 2 | 2010 | 1321 | 0.050 |
Why?
| | Citrobacter | 1 | 1982 | 2 | 0.050 |
Why?
| | Diagnostic Imaging | 1 | 2005 | 320 | 0.050 |
Why?
| | Abducens Nerve Injury | 1 | 2002 | 1 | 0.050 |
Why?
| | Oculomotor Nerve Injuries | 1 | 2002 | 1 | 0.050 |
Why?
| | Cohort Studies | 3 | 2017 | 5744 | 0.050 |
Why?
| | Positive-Pressure Respiration | 1 | 1983 | 104 | 0.050 |
Why?
| | Young Adult | 2 | 2016 | 13371 | 0.050 |
Why?
| | Radiography, Thoracic | 1 | 1983 | 172 | 0.050 |
Why?
| | Enterobacteriaceae Infections | 1 | 1982 | 43 | 0.050 |
Why?
| | Pectoralis Muscles | 1 | 1981 | 19 | 0.040 |
Why?
| | Electroretinography | 1 | 2021 | 50 | 0.040 |
Why?
| | Hydrocephalus | 1 | 1982 | 108 | 0.040 |
Why?
| | Tibial Fractures | 1 | 1982 | 68 | 0.040 |
Why?
| | Patient Education as Topic | 2 | 2003 | 766 | 0.040 |
Why?
| | Infant, Premature | 2 | 2017 | 580 | 0.040 |
Why?
| | Medical Records | 1 | 2001 | 183 | 0.040 |
Why?
| | Parents | 2 | 2006 | 1423 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2005 | 2849 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 581 | 0.040 |
Why?
| | Cataract | 1 | 2003 | 221 | 0.040 |
Why?
| | Appendicitis | 1 | 1982 | 139 | 0.040 |
Why?
| | Acute Disease | 2 | 2019 | 993 | 0.040 |
Why?
| | Steroids | 1 | 2001 | 163 | 0.040 |
Why?
| | Administration, Oral | 2 | 2017 | 787 | 0.040 |
Why?
| | Eosinophilia | 1 | 1982 | 218 | 0.040 |
Why?
| | Risk | 3 | 1989 | 913 | 0.040 |
Why?
| | Therapeutic Irrigation | 1 | 1999 | 79 | 0.040 |
Why?
| | Colon | 1 | 1982 | 284 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2005 | 569 | 0.040 |
Why?
| | Chlorambucil | 1 | 1999 | 10 | 0.040 |
Why?
| | Vitreous Hemorrhage | 1 | 1999 | 9 | 0.040 |
Why?
| | Leukemia | 1 | 1981 | 241 | 0.040 |
Why?
| | Sodium Chloride | 1 | 1999 | 138 | 0.040 |
Why?
| | Physical Therapy Modalities | 1 | 1982 | 308 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 4 | 1999 | 2697 | 0.040 |
Why?
| | Lens, Crystalline | 1 | 1999 | 132 | 0.040 |
Why?
| | Corneal Pachymetry | 1 | 2017 | 15 | 0.030 |
Why?
| | Streptococcus pneumoniae | 1 | 1999 | 169 | 0.030 |
Why?
| | Risk Assessment | 2 | 2017 | 3466 | 0.030 |
Why?
| | Prednisone | 1 | 1999 | 226 | 0.030 |
Why?
| | Blister | 1 | 2017 | 40 | 0.030 |
Why?
| | Fluorometholone | 1 | 2017 | 4 | 0.030 |
Why?
| | Brain | 1 | 2010 | 2791 | 0.030 |
Why?
| | Administration, Intranasal | 1 | 2017 | 91 | 0.030 |
Why?
| | Biological Availability | 1 | 2017 | 137 | 0.030 |
Why?
| | Bone Marrow | 1 | 1999 | 299 | 0.030 |
Why?
| | Quality of Life | 2 | 2006 | 2962 | 0.030 |
Why?
| | Optometry | 1 | 1997 | 9 | 0.030 |
Why?
| | Intraoperative Period | 1 | 1997 | 67 | 0.030 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2017 | 34 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2018 | 191 | 0.030 |
Why?
| | Body Weight | 1 | 2001 | 996 | 0.030 |
Why?
| | Administration, Topical | 1 | 1997 | 149 | 0.030 |
Why?
| | Laser Coagulation | 1 | 2017 | 71 | 0.030 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2016 | 20 | 0.030 |
Why?
| | Battered Child Syndrome | 2 | 1992 | 7 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2004 | 1569 | 0.030 |
Why?
| | Rupture | 1 | 2016 | 88 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 157 | 0.030 |
Why?
| | Prognosis | 3 | 2020 | 3995 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2016 | 174 | 0.030 |
Why?
| | Eye | 1 | 2016 | 112 | 0.030 |
Why?
| | Apoptosis | 2 | 2016 | 2551 | 0.030 |
Why?
| | Uveomeningoencephalitic Syndrome | 1 | 1995 | 8 | 0.030 |
Why?
| | Sarcoidosis | 1 | 2017 | 162 | 0.030 |
Why?
| | Surgical Wound Dehiscence | 1 | 1994 | 22 | 0.030 |
Why?
| | Agenesis of Corpus Callosum | 1 | 1994 | 13 | 0.030 |
Why?
| | Scotoma | 1 | 1994 | 7 | 0.030 |
Why?
| | Choroid Diseases | 1 | 1994 | 11 | 0.030 |
Why?
| | Choroiditis | 1 | 1994 | 6 | 0.030 |
Why?
| | Pilot Projects | 1 | 2000 | 1765 | 0.030 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 260 | 0.030 |
Why?
| | Accidents, Home | 1 | 2013 | 33 | 0.030 |
Why?
| | Ophthalmoplegia | 1 | 1993 | 13 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 1993 | 48 | 0.030 |
Why?
| | Contraindications | 1 | 1993 | 86 | 0.030 |
Why?
| | Facial Paralysis | 1 | 1993 | 24 | 0.030 |
Why?
| | Tamoxifen | 1 | 1994 | 202 | 0.030 |
Why?
| | Iris | 1 | 1993 | 22 | 0.030 |
Why?
| | Surgery, Plastic | 1 | 1994 | 46 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1232 | 0.030 |
Why?
| | Dark Adaptation | 1 | 2013 | 13 | 0.020 |
Why?
| | Aviation | 1 | 2013 | 8 | 0.020 |
Why?
| | Mass Screening | 1 | 2021 | 1296 | 0.020 |
Why?
| | Fungemia | 1 | 1992 | 9 | 0.020 |
Why?
| | Cranial Fossa, Posterior | 1 | 1992 | 18 | 0.020 |
Why?
| | Ocular Physiological Phenomena | 1 | 1992 | 10 | 0.020 |
Why?
| | Aspergillosis | 1 | 1992 | 21 | 0.020 |
Why?
| | Candidiasis | 1 | 1992 | 63 | 0.020 |
Why?
| | Eye Diseases | 1 | 1993 | 90 | 0.020 |
Why?
| | Irritants | 1 | 2012 | 44 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 665 | 0.020 |
Why?
| | Vision Disorders | 1 | 1993 | 157 | 0.020 |
Why?
| | Emergencies | 2 | 2009 | 178 | 0.020 |
Why?
| | Mycoses | 1 | 1992 | 82 | 0.020 |
Why?
| | Vision Disparity | 1 | 1991 | 3 | 0.020 |
Why?
| | Heparin | 1 | 2013 | 258 | 0.020 |
Why?
| | Radiography | 3 | 1985 | 839 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2047 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2018 | 635 | 0.020 |
Why?
| | Thrombocytopenia | 1 | 2013 | 205 | 0.020 |
Why?
| | Sex Factors | 3 | 1987 | 2050 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1090 | 0.020 |
Why?
| | Coloboma | 1 | 1990 | 5 | 0.020 |
Why?
| | Aged, 80 and over | 4 | 2005 | 7685 | 0.020 |
Why?
| | Pigment Epithelium of Eye | 1 | 1990 | 36 | 0.020 |
Why?
| | Retinal Perforations | 1 | 1990 | 19 | 0.020 |
Why?
| | Safflower Oil | 1 | 1990 | 5 | 0.020 |
Why?
| | Crohn Disease | 1 | 1994 | 250 | 0.020 |
Why?
| | Light Coagulation | 1 | 1990 | 9 | 0.020 |
Why?
| | Soybean Oil | 1 | 1990 | 14 | 0.020 |
Why?
| | Sacroiliac Joint | 2 | 1994 | 34 | 0.020 |
Why?
| | Emulsions | 1 | 1990 | 55 | 0.020 |
Why?
| | HEPES | 1 | 1989 | 2 | 0.020 |
Why?
| | Chondroitin | 1 | 1989 | 6 | 0.020 |
Why?
| | Tissue Preservation | 1 | 1989 | 12 | 0.020 |
Why?
| | Lung | 1 | 1983 | 4103 | 0.020 |
Why?
| | Propionibacterium acnes | 1 | 1989 | 10 | 0.020 |
Why?
| | Chondroitin Sulfates | 1 | 1989 | 31 | 0.020 |
Why?
| | Graft Rejection | 1 | 1992 | 534 | 0.020 |
Why?
| | Nocardia asteroides | 1 | 1989 | 1 | 0.020 |
Why?
| | Sulfacetamide | 1 | 1989 | 1 | 0.020 |
Why?
| | Trimethoprim | 1 | 1989 | 7 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 1989 | 7 | 0.020 |
Why?
| | Gentamicins | 1 | 1989 | 52 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 1993 | 489 | 0.020 |
Why?
| | Indians, North American | 1 | 1995 | 645 | 0.020 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 1989 | 42 | 0.020 |
Why?
| | Antioxidants | 1 | 2012 | 593 | 0.020 |
Why?
| | Phospholipids | 1 | 1990 | 219 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1810 | 0.020 |
Why?
| | Anticoagulants | 1 | 2013 | 667 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2016 | 2480 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 1990 | 208 | 0.020 |
Why?
| | Forensic Medicine | 1 | 2007 | 17 | 0.020 |
Why?
| | Brain Injuries | 1 | 1992 | 500 | 0.020 |
Why?
| | Recurrence | 1 | 1990 | 1085 | 0.020 |
Why?
| | Piperazines | 1 | 1989 | 345 | 0.020 |
Why?
| | Orbit Evisceration | 1 | 2006 | 1 | 0.020 |
Why?
| | Forensic Pathology | 1 | 2006 | 7 | 0.020 |
Why?
| | Dacryocystorhinostomy | 1 | 2006 | 12 | 0.020 |
Why?
| | Hawaii | 1 | 1986 | 36 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2006 | 57 | 0.020 |
Why?
| | Chromosome Disorders | 1 | 1986 | 43 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1986 | 175 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 3984 | 0.020 |
Why?
| | Klebsiella pneumoniae | 1 | 1985 | 46 | 0.010 |
Why?
| | Wounds, Nonpenetrating | 1 | 2009 | 303 | 0.010 |
Why?
| | Informed Consent | 1 | 1986 | 188 | 0.010 |
Why?
| | Hirschsprung Disease | 1 | 1985 | 89 | 0.010 |
Why?
| | Tablets | 1 | 1984 | 41 | 0.010 |
Why?
| | Penicillin Resistance | 1 | 1983 | 8 | 0.010 |
Why?
| | Ulcer | 1 | 1984 | 34 | 0.010 |
Why?
| | Mitral Valve | 1 | 1984 | 96 | 0.010 |
Why?
| | Abdominal Muscles | 1 | 1983 | 12 | 0.010 |
Why?
| | Meningitis, Haemophilus | 1 | 1983 | 6 | 0.010 |
Why?
| | Arthritis, Infectious | 1 | 1985 | 69 | 0.010 |
Why?
| | Arthritis, Rheumatoid | 1 | 1992 | 1165 | 0.010 |
Why?
| | Hernia, Umbilical | 1 | 1983 | 20 | 0.010 |
Why?
| | Length of Stay | 1 | 1989 | 1237 | 0.010 |
Why?
| | Haemophilus influenzae | 1 | 1983 | 63 | 0.010 |
Why?
| | Health Services Misuse | 1 | 1983 | 33 | 0.010 |
Why?
| | Angiostrongylus | 1 | 1982 | 1 | 0.010 |
Why?
| | Nematode Infections | 1 | 1982 | 5 | 0.010 |
Why?
| | Feces | 1 | 1985 | 481 | 0.010 |
Why?
| | Age Distribution | 1 | 2003 | 401 | 0.010 |
Why?
| | Infant, Premature, Diseases | 1 | 1983 | 105 | 0.010 |
Why?
| | Rupture, Spontaneous | 1 | 1982 | 15 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2005 | 1317 | 0.010 |
Why?
| | Contracture | 1 | 1982 | 21 | 0.010 |
Why?
| | Kidney | 1 | 1990 | 1467 | 0.010 |
Why?
| | Leukemia, Lymphoid | 1 | 1981 | 27 | 0.010 |
Why?
| | Enema | 1 | 1982 | 47 | 0.010 |
Why?
| | Attitude of Health Personnel | 2 | 1987 | 1159 | 0.010 |
Why?
| | Age Factors | 1 | 1989 | 3276 | 0.010 |
Why?
| | Glucagon | 1 | 1982 | 104 | 0.010 |
Why?
| | Elbow Joint | 1 | 1982 | 75 | 0.010 |
Why?
| | Regression Analysis | 1 | 2003 | 1021 | 0.010 |
Why?
| | Skin | 1 | 1985 | 756 | 0.010 |
Why?
| | Hip Joint | 1 | 1982 | 169 | 0.010 |
Why?
| | Contrast Media | 1 | 1982 | 463 | 0.010 |
Why?
| | Knee Joint | 1 | 1982 | 407 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2006 | 5530 | 0.010 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 1981 | 633 | 0.010 |
Why?
| | Spasm | 1 | 1994 | 21 | 0.010 |
Why?
| | Spondylitis | 1 | 1994 | 2 | 0.010 |
Why?
| | Sulfasalazine | 1 | 1994 | 23 | 0.010 |
Why?
| | Tenosynovitis | 1 | 1994 | 12 | 0.010 |
Why?
| | Crystallization | 1 | 1994 | 147 | 0.010 |
Why?
| | Cadaver | 1 | 1994 | 295 | 0.010 |
Why?
| | Middle East | 1 | 1993 | 17 | 0.010 |
Why?
| | Accommodation, Ocular | 1 | 1993 | 14 | 0.010 |
Why?
| | Rib Fractures | 1 | 1992 | 33 | 0.010 |
Why?
| | Posture | 1 | 1993 | 192 | 0.010 |
Why?
| | Muscles | 1 | 1993 | 332 | 0.010 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 1994 | 358 | 0.010 |
Why?
| | Reference Values | 1 | 1992 | 801 | 0.010 |
Why?
| | Postoperative Care | 1 | 1991 | 273 | 0.000 |
Why?
| | Drug Contamination | 1 | 1989 | 52 | 0.000 |
Why?
| | Culture Media | 1 | 1989 | 164 | 0.000 |
Why?
| | Macular Degeneration | 1 | 1990 | 166 | 0.000 |
Why?
| | Technetium Tc 99m Medronate | 1 | 1985 | 3 | 0.000 |
Why?
| | Suppuration | 1 | 1985 | 9 | 0.000 |
Why?
| | Gallium Radioisotopes | 1 | 1985 | 14 | 0.000 |
Why?
| | Radionuclide Imaging | 1 | 1985 | 116 | 0.000 |
Why?
| | Breast Neoplasms | 1 | 1994 | 2283 | 0.000 |
Why?
| | Aging | 1 | 1990 | 1857 | 0.000 |
Why?
| | Pediatrics | 1 | 1987 | 1079 | 0.000 |
Why?
|
|
Enzenauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|